Cannula approach using posterior delivery brings unparalleled safety


Posterior juxtascleral injection of he angiostatic steroid analog anecortave acetate (Alcon) has been associated with a remarkable safety profile in clinical trials evaluating it for the treatment of subfoveal choroidal neorvascularization (CNV) associated with age-related macular degeneration (AMD).

Related Videos
© 2023 MJH Life Sciences

All rights reserved.